Back to Search
Start Over
Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis
Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis
- Source :
- JAAD Case Reports, Vol 6, Iss 3, Pp 219-221 (2020), JAAD Case Reports
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Adalimumab (Humira; Abbott Laboratories, Puerto Rico) is a recombinant human IgG1 monoclonal antibody for tumor necrosis factor and is a treatment option for both hidradenitis suppurativa (HS) and rheumatoid arthritis (RA). We report a case of a patient with lichen planopilaris (LPP) that had hair regrowth when treated with adalimumab, originally prescribed to the patient for RA and HS.
- Subjects :
- rheumatoid arthritis
musculoskeletal diseases
medicine.medical_specialty
medicine.drug_class
frontal fibrosing alopecia
HS, hidradenitis suppurativa
RA, rheumatoid arthritis
Case Report
Dermatology
LPP, lichen planopilaris
Monoclonal antibody
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
adalimumab
lcsh:Dermatology
medicine
Adalimumab
Hidradenitis suppurativa
skin and connective tissue diseases
business.industry
Frontal fibrosing alopecia
hidradenitis suppurativa
Treatment options
lcsh:RL1-803
medicine.disease
Lichen planopilaris
humanities
lichen planopilaris
030220 oncology & carcinogenesis
Rheumatoid arthritis
Tumor necrosis factor alpha
business
hair regrowth
medicine.drug
Subjects
Details
- ISSN :
- 23525126
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- JAAD Case Reports
- Accession number :
- edsair.doi.dedup.....49286a4b2051c7b324e1e3b16f865488
- Full Text :
- https://doi.org/10.1016/j.jdcr.2019.12.016